Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of the study is to evaluate the efficacy and toxicity of fludarabine with pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in patients with platinum resistant or refractory ovarian cancer.
Epistemonikos ID: 494ebc53aea97fcfac28e3bc4ab5d67a04001c1f
First added on: May 21, 2024